N-acetylglucosamine-6-sulfatase: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
[[Category:Lysosomal storage diseases]] | [[Category:Lysosomal storage diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 03:53, 11 February 2025
N-acetylglucosamine-6-sulfatase (G6S) is an enzyme that is involved in the degradation of glycosaminoglycans in the body. This enzyme is encoded by the G6S gene in humans.
Function
N-acetylglucosamine-6-sulfatase is a lysosomal enzyme that catalyzes the removal of 6-sulfate groups from the N-acetyl-D-glucosamine 6-sulfate units of keratan sulfate and chondroitin sulfate. The enzyme is a member of the sulfatase family, which is a group of enzymes that catalyze the hydrolysis of sulfuric acid esters.
Clinical significance
Deficiency of N-acetylglucosamine-6-sulfatase leads to the lysosomal storage disorder Mucopolysaccharidosis type IIID (MPS IIID), also known as Sanfilippo syndrome type D. This is a rare and severe neurodegenerative disorder characterized by progressive mental and motor deterioration, leading to severe disability and death in early adulthood.
Structure
The G6S gene is located on the long arm of chromosome 12 (12q14) and spans approximately 40 kilobases. The gene encodes a protein of 552 amino acids with a calculated molecular mass of 63 kDa.
See also
References
<references />
